{"nctId":"NCT00487240","briefTitle":"Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes","startDateStruct":{"date":"2007-06"},"conditions":["Diabetes Mellitus, Type 1"],"count":387,"armGroups":[{"label":"Insulin Lispro Protamine Suspension","type":"EXPERIMENTAL","interventionNames":["Drug: Insulin Lispro Protamine Suspension"]},{"label":"Detemir","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Insulin Levemir"]}],"interventions":[{"name":"Insulin Lispro Protamine Suspension","otherNames":["ILPS","NPL","Humalog","LY275585"]},{"name":"Insulin Levemir","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical diagnosis of type 1 diabetes for one year or more\n* Age 18 years or older\n* Body mass index (BMI) less than or equal to 35 kilograms per square meter (kg/m2)\n* Have a hemoglobin A1c (HbA1c) 1.2 to 2.0 times the upper limit of the normal (ULN) reference range within 30 days prior to Visit 1 or collected and analyzed at a local laboratory at Visit 1\n* As determined by the investigator, are capable and willing to do the following:\n\n  * perform self monitoring of blood glucose (SMBG),\n  * complete patient diaries as required for this protocol,\n  * use the insulin injection device(s) according to the instructions provided,\n  * are receptive to diabetes education,\n  * comply with the required study visits.\n\nExclusion Criteria:\n\n* Have taken any oral antihyperglycemic medications (OAMs) within 3 months prior to Visit 1.\n* Have had more than one episode of severe hypoglycemia, as defined in the Abbreviations and Definitions section of the protocol, within 6 months prior to entry into the study\n* Are pregnant or intend to become pregnant during the course of the study or are sexually active women of childbearing potential not actively practicing birth control by a method determined by the investigator to be medically acceptable or women who are breastfeeding\n* Are receiving chronic (lasting longer than 14 consecutive days) systemic glucocorticoid therapy (excluding topical, intra-articular, intraocular, and inhaled preparations) or have received such therapy within the 4 weeks immediately preceding Visit 1.\n* Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Hemoglobin A1c (HbA1c) From Baseline to Endpoint","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.88","spread":"0.10"},{"groupId":"OG001","value":"8.68","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.69","spread":"0.07"},{"groupId":"OG001","value":"-0.59","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Actual and Change From Baseline Hemoglobin A1c (HbA1c) Values","description":"The summary statistics represents the mean of all subjects. Change from baseline is calculated for each individual subject for the specific visit and then the \"mean change from baseline\" is calculated by averaging out for all subjects. \\[Sum over all (i) {A1c at Week 8 for Subject(i) minus A1c Baseline for Subject (i)}/Total Subjects\\]. Therefore, for example, the Change from Baseline is not equal to the difference of Mean A1c for Week 8 minus Mean A1c for baseline.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.88","spread":"0.10"},{"groupId":"OG001","value":"8.68","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.08","spread":"0.07"},{"groupId":"OG001","value":"8.11","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.68","spread":"0.07"},{"groupId":"OG001","value":"-0.64","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.94","spread":"0.07"},{"groupId":"OG001","value":"8.08","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.81","spread":"0.07"},{"groupId":"OG001","value":"-0.67","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.07","spread":"0.08"},{"groupId":"OG001","value":"8.11","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.69","spread":"0.08"},{"groupId":"OG001","value":"-0.65","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.09","spread":"0.08"},{"groupId":"OG001","value":"8.14","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.68","spread":"0.08"},{"groupId":"OG001","value":"-0.62","spread":"0.08"}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients With Hemoglobin A1c (HbA1c) Less Than or Equal to 7.0% and HbA1c Less Than or Equal to 6.5%","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"18.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81.5","spread":null},{"groupId":"OG001","value":"81.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.2","spread":null},{"groupId":"OG001","value":"15.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"84.8","spread":null},{"groupId":"OG001","value":"84.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.7","spread":null},{"groupId":"OG001","value":"9.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.3","spread":null},{"groupId":"OG001","value":"90.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":null},{"groupId":"OG001","value":"8.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92.9","spread":null},{"groupId":"OG001","value":"91.8","spread":null}]}]}]},{"type":"SECONDARY","title":"7-Point Self-Monitored Blood Glucose (SMBG) at Endpoint","description":"Actual daily mean blood glucose levels at endpoint. The SMBG excursion is the difference between the postprandial and preprandial blood glucose concentration taken at the morning, midday and evening meals.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.67","spread":"1.97"},{"groupId":"OG001","value":"8.48","spread":"1.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.77","spread":"2.37"},{"groupId":"OG001","value":"8.56","spread":"2.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.70","spread":"2.08"},{"groupId":"OG001","value":"8.58","spread":"2.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.00","spread":"2.55"},{"groupId":"OG001","value":"8.75","spread":"2.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.09","spread":"3.18"},{"groupId":"OG001","value":"8.62","spread":"3.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.68","spread":"2.89"},{"groupId":"OG001","value":"8.56","spread":"2.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.29","spread":"2.92"},{"groupId":"OG001","value":"8.19","spread":"2.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.54","spread":"2.49"},{"groupId":"OG001","value":"8.61","spread":"2.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.92","spread":"2.72"},{"groupId":"OG001","value":"8.87","spread":"2.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.05","spread":"2.97"},{"groupId":"OG001","value":"8.60","spread":"2.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.49","spread":"2.85"},{"groupId":"OG001","value":"8.29","spread":"2.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.34","spread":"2.94"},{"groupId":"OG001","value":"-0.12","spread":"2.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.38","spread":"2.52"},{"groupId":"OG001","value":"0.46","spread":"2.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"2.72"},{"groupId":"OG001","value":"-0.24","spread":"3.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"1.68"},{"groupId":"OG001","value":"0.01","spread":"1.71"}]}]}]},{"type":"SECONDARY","title":"Glycemic Variability at Endpoint","description":"Glycemic variability was measured by standard deviation (SD) value of fasting blood glucose as measured by intra-patient glycemic variability (determined by the 7-point self-monitored blood glucose \\[SMBG\\] profiles at endpoint); mean value (M-value), which was the mean of the intra-days self-monitored blood glucose values, and by the mean of daily difference (MODD), which was the mean of the between-days self-monitored blood glucose values.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.64","spread":"2.09"},{"groupId":"OG001","value":"2.30","spread":"1.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.39","spread":"31.82"},{"groupId":"OG001","value":"32.19","spread":"25.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.04","spread":"1.90"},{"groupId":"OG001","value":"2.78","spread":"1.79"}]}]}]},{"type":"SECONDARY","title":"Number of Self-Reported Hypoglycemic Episodes (Including Nocturnal, Non-Nocturnal, and Severe Hypoglycemia) Overall and at Endpoint","description":"Nocturnal: Defined as any hypoglycemic event that occurs between bedtime and waking. Non-Nocturnal: Defined as any hypoglycemic event that occurs between waking and bedtime. Severe: An episode with symptoms consistent with neuroglycopenia in which the patient requires the assistance of another person; associated with either a blood glucose level of \\<2.8 mmol/L (\\<50 mg/dL) or prompt recovery after oral carbohydrate, glucagon, or intravenous glucose.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"135","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null},{"groupId":"OG001","value":"173","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125","spread":null},{"groupId":"OG001","value":"111","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"127","spread":null},{"groupId":"OG001","value":"129","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"172","spread":null},{"groupId":"OG001","value":"172","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"1-Year Adjusted Rates of Self-Reported Hypoglycemic Episodes (Including Nocturnal, Non-Nocturnal, and Severe) Overall and at Endpoint","description":"Nocturnal: Defined as any hypoglycemic event that occurs between bedtime and waking. Non-Nocturnal: Defined as any hypoglycemic event that occurs between waking and bedtime. Severe: An episode with symptoms consistent with neuroglycopenia in which the patient requires the assistance of another person; associated with either a blood glucose level of \\<2.8 mmol/L (\\<50 mg/dL) or prompt recovery after oral carbohydrate, glucagon, or intravenous glucose.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.41","spread":"90.91"},{"groupId":"OG001","value":"52.60","spread":"70.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.45","spread":"85.07"},{"groupId":"OG001","value":"61.21","spread":"64.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.90","spread":"18.65"},{"groupId":"OG001","value":"5.60","spread":"13.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.65","spread":"15.01"},{"groupId":"OG001","value":"6.01","spread":"10.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.08","spread":"83.17"},{"groupId":"OG001","value":"46.88","spread":"65.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.58","spread":"78.63"},{"groupId":"OG001","value":"54.83","spread":"58.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.63","spread":"3.08"},{"groupId":"OG001","value":"0.10","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":"1.43"},{"groupId":"OG001","value":"0.25","spread":"1.26"}]}]}]},{"type":"SECONDARY","title":"30-Day Adjusted Rates of Self-Reported Hypoglycemic Episodes (Including Nocturnal, Non-Nocturnal, and Severe) Overall and at Endpoint","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.45","spread":"7.47"},{"groupId":"OG001","value":"4.32","spread":"5.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.28","spread":"6.99"},{"groupId":"OG001","value":"5.03","spread":"5.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.73","spread":"1.53"},{"groupId":"OG001","value":"0.46","spread":"1.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.79","spread":"1.23"},{"groupId":"OG001","value":"0.49","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.69","spread":"6.83"},{"groupId":"OG001","value":"3.85","spread":"5.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.47","spread":"6.46"},{"groupId":"OG001","value":"4.50","spread":"4.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.25"},{"groupId":"OG001","value":"0.01","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.03","spread":"0.12"},{"groupId":"OG001","value":"0.02","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Absolute Body Weight at 32 Week Endpoint","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.76","spread":"15.53"},{"groupId":"OG001","value":"72.69","spread":"14.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.54","spread":"3.18"},{"groupId":"OG001","value":"0.58","spread":"3.19"}]}]}]},{"type":"SECONDARY","title":"Insulin Dose Per Body Weight (Total and By Component [Basal and Bolus])","description":"Total daily insulin dose adjusted for body weight (U/kg/day) was assessed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.91","spread":"0.30"},{"groupId":"OG001","value":"0.99","spread":"0.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.39","spread":"0.17"},{"groupId":"OG001","value":"0.45","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.53","spread":"0.20"},{"groupId":"OG001","value":"0.55","spread":"0.26"}]}]}]},{"type":"SECONDARY","title":"Insulin Dose (Total and By Component [Basal and Bolus])","description":"Total daily insulin dose (U/day) was assessed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.78","spread":"27.42"},{"groupId":"OG001","value":"73.84","spread":"38.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.94","spread":"14.69"},{"groupId":"OG001","value":"33.32","spread":"20.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.99","spread":"17.37"},{"groupId":"OG001","value":"40.70","spread":"22.29"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10},"commonTop":["Nasopharyngitis","Headache","Influenza","Cough","Sinusitis"]}}}